Comparative Study
Journal Article
Add like
Add dislike
Add to saved papers

Evaluation of glomerular filtration rate by different equations in Chinese elderly with chronic kidney disease.

PURPOSE: Performance of equations in elderly with chronic kidney disease (CKD) was debated. We aimed to access the performances of estimating equations for glomerular filtration rate in Chinese elderly population with chronic kidney disease.

METHODS: Participants [N = 218, median age, 82 (range 75-96)] with CKD underwent renal dynamic imaging using technetium-99m diethylene-triamine-penta-acetic acid (99mTc-DTPA). The performances of glomerular filtration rate equations including the Cockcroft-Gault equation, the MDRD (Modification of Diet in Renal Disease) equation for Chinese, 3 CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equations, and 2 BIS (Berlin Initiative Study) equations were compared.

RESULTS: Median mGFR was 47.62 (3.00-135.00) ml/min/1.73 m2 . Smaller biases were shown in BIS-2 equation and CKD-EPI-Cr equation (0.63 ml/min/1.73 m2 and -1.22 ml/min/1.73 m2 ). Interquartile range of the differences was least with BIS-2 equation and CKD-EPI-Cr-Cys equation (4.36 ml/min/1.73 m2 and 9.17 ml/min/1.73 m2 ). For accuracy (percentage of eGFR within 30 % of the mGFR, P30), performance of BIS-2, CKD-EPI-Cr-Cys, and BIS-1 equation was superior (94.50, 89.91, and 88.53 %, respectively). In terms of accuracy (root-mean-square error, RMSE), BIS-2 equation, CKD-EPI-Cr-Cys equation, and BIS-1 equation also performed better (7.21 ml/min/1.73 m2 , 8.87 ml/min/1.73 m2 and 9.82 ml/min/1.73 m2 ). GFR category misclassification rates were smaller in BIS-2 equation, CKD-EPI-Cr-Cys equation and BIS-1 equation (16.51, 20.64, and 25.69 %, respectively).

CONCLUSION: Compared with other equations, the BIS-2 equation performed better in the estimation of glomerular filtration rate for Chinese elderly with CKD aged 75 or above.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app